Health
Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market
This article is for subscribers only.
Hims & Hers Health Inc. shares dropped the most in their five-year history after Amazon.com Inc. said it would start marketing drugs to fight hair loss, an important component of the telehealth company’s business.
Hims fell as much as 18% Thursday, the most intraday since the shares began trading in September 2019. They had tripled this year through Wednesday’s close as its sales of GLP-1 weight-loss drugs skyrocketed.